+467.0%
MRNA vs PFGC
-10.1%
+477.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | PFGC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -0.4% | +5.8% | +5.3% |
| 7D | -1.1% | -4.8% | +3.7% | -1.8% |
| 30D | +126.1% | -12.5% | +138.7% | +123.0% |
| 3M | +190.0% | -9.7% | +199.8% | +184.2% |
| 6M | +157.2% | +7.0% | +150.2% | +147.4% |
| YTD | +388.2% | +4.5% | +383.7% | +376.2% |
| 1Y | +467.0% | -11.6% | +478.6% | +440.9% |
| All | +467.0% | -10.1% | +477.1% | +440.9% |
Cumulative growth
Daily Returns
Daily percentage return beside PFGC.
Daily Out/Under-Performance
Portfolio return minus PFGC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PFGC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded PFGC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling